ATOPIC DERMATITIS ECZEMA
Clinical trials for ATOPIC DERMATITIS ECZEMA explained in plain language.
Never miss a new study
Get alerted when new ATOPIC DERMATITIS ECZEMA trials appear
Sign up with your email to follow new studies for ATOPIC DERMATITIS ECZEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Light vs lotion: Head-to-Head eczema battle
Disease control OngoingThis study tests whether adding UVB light therapy to standard skin creams works better than using creams alone for adults with moderate-to-severe eczema. 316 participants were randomly assigned to receive either the light therapy plus creams or just creams for at least 3 months. …
Matched conditions: ATOPIC DERMATITIS ECZEMA
Phase: NA • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Baby skin cream trial aims to stop allergies before they start
Prevention OngoingThis study tests whether using special skin barrier creams and a steroid cream regularly (proactive care) in babies who already have eczema can prevent them from developing food allergies. It compares this approach to only treating eczema when it flares up (reactive care). The go…
Matched conditions: ATOPIC DERMATITIS ECZEMA
Phase: PHASE2 • Sponsor: Kari Nadeau, MD, PhD • Aim: Prevention
Last updated Apr 03, 2026 14:43 UTC
-
Could your breast milk hold the key to your Baby's allergies?
Knowledge-focused OngoingThis study aims to understand if specific tiny molecules in a mother's breast milk affect her baby's chance of developing common allergic conditions like eczema, wheezing, or food allergies. Researchers will follow 221 breastfeeding mother-baby pairs for a year, collecting breast…
Matched conditions: ATOPIC DERMATITIS ECZEMA
Sponsor: Milton S. Hershey Medical Center • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC
-
A randomized, double-blind, placebo-controlled, multicenter, phase 2 study to evaluate the efficacy and safety of HY209 gel in patients with mild to moderate atopic Dermatitis(AD)
OngoingThis is a randomized, double-blind, placebo-controlled, multi-center, phase 2 study in patients with mild to moderate Atopic Dermatitis(AD), which consists of 2 parts.
Matched conditions: ATOPIC DERMATITIS ECZEMA
Phase: PHASE2 • Sponsor: Shaperon
Last updated Mar 02, 2026 15:22 UTC